East Tennessee Cardiovascular Surgery Group — Knoxville, Tennessee

East Tennessee Cardiovascular Surgery Group is a clinical research site located in Knoxville, Tennessee, United States 37923.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

East Tennessee Cardiovascular Surgery Group has participated in 2 clinical trials.

Therapeutic areas: Class IV Angina, Bloodloss, Surgical Procedures, Operative.

Sponsors: Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc., Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA).

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for East Tennessee Cardiovascular Surgery Group?

East Tennessee Cardiovascular Surgery Group has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has East Tennessee Cardiovascular Surgery Group conducted?

East Tennessee Cardiovascular Surgery Group has 2 clinical trials on record. Their work covers Class IV Angina, Bloodloss, Surgical Procedures, Operative.

Is East Tennessee Cardiovascular Surgery Group accredited by Crixeo Health?

East Tennessee Cardiovascular Surgery Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about East Tennessee Cardiovascular Surgery Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.